alexa
Reach Us +44-1202068036
Knockdown Of SALL4 Enhances All-trans Retinoic Acid (ATRA)-induced Acute Myeloid Leukemia (AML) Cell Differentiation | 19856
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Hematology & Blood Disorders

Jianchang Yang, Li Liu and Yupo Ma
ScientificTracks Abstracts: J Blood Disorders Transf
DOI: 10.4172/2155-9864.S1.006
Abstract
ATRA is a differentiation agent that revolutionized the treatment of a rare subtype of AML (APL, 5~10% of AML). However, it has not been useful for other subtypes of AML. Here, we explore the effect of SALL4, a newly identified stem cell factor, on cellular differentiation and growth arrest in the presence of ATRA treatment. Aberrant SALL4 protein expression has been found in all types of AML patient samples, while in normal blood cells, SALL4 expression is only restricted in the hematopoietic stem/progenitor cell (HSPC) populations. The reason is that SALL4 activation in AML may prevent the blast cells from differentiating and/or protect self-renewal that was normally seen in HSPCs. Indeed, in both APL and non- APL AML cells, a ~75% reduction of SALL4 levels caused significant upregulation of CD11B positive differentiated myeloid cells, along with a correspondingly increasing of apoptotic marker Annexin V activity. In these cells, co-treatment of ATRA induced further increment of cellular differentiation and growth arrest as judged by Wright-Giemsa staining, superoxide anion production and flow cytometry assays. In addition, SALL4 knockdown and ATRA exhibit a synergistic enhancement in impairing tumor growth in a mouse xenograft model of AML cells. Further molecular studies confirmed that SALL4 associates with retinoic acid receptor A (RARA) and modulates ATRA-regulated target genes. These results suggest that SALL4 functions asa component of the RAR co-repressor complex with an inhibitory effect on ATRA-induced cellular differentiation and that SALL4 plays a role in ATRA-mediated differentiation as an important aspect of leukemia therapy.
Biography
Jianchang Yang received his MD from XinJiang University of Medical Sciences in China and his PhD in Molecular Cardiology from Charite University Medicine (Berlin)-magna cum laude - in Germany. His research interests include the development of novel therapies for acute myeloid leukemia, using new approaches to killing leukemia stem cells; somatic cell reprogramming and the generation of patient-specific pluripotent progenitor cells for clinical therapies. He has published more than 23 papers in high impact journals.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

streamtajm

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version